Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial

[1]  J. Liao,et al.  Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. , 2011, International journal of oncology.

[2]  J. Russo,et al.  Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. , 2011, Cancer research.

[3]  J. Liao,et al.  The Effects of Tamoxifen and Fish Oil on Mammary Carcinogenesis in Polyoma Middle T Transgenic Mice , 2011, Hormones & cancer.

[4]  R. Sinha,et al.  Diet index-based and empirically derived dietary patterns are associated with colorectal cancer risk. , 2010, The Journal of nutrition.

[5]  J. Philbrick,et al.  Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Yan Li,et al.  Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. , 2010, The American journal of clinical nutrition.

[7]  Richard D Bruggeman,et al.  The Impact of Fish Oil on the Chemopreventive Efficacy of Tamoxifen against Development of N-Methyl-N-Nitrosourea–Induced Rat Mammary Carcinogenesis , 2010, Cancer Prevention Research.

[8]  Erika A. Waters,et al.  Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[9]  S. Hankinson,et al.  Circulating 2-Hydroxy- and 16α-Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women , 2008, Cancer Epidemiology Biomarkers & Prevention.

[10]  Norman Wolmark,et al.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.

[11]  A. Neugut,et al.  Relationship between Urinary 15-F2t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[12]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[13]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[14]  D. Midthune,et al.  Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. , 2001, American journal of epidemiology.

[15]  B. Bonanni,et al.  Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer , 2001, British Journal of Cancer.

[16]  P. Lips,et al.  Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis. , 2001, The Journal of clinical endocrinology and metabolism.

[17]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[18]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[19]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.

[20]  P. P. Toth,et al.  Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia , 2011 .

[21]  John L Hopper,et al.  Mammographic density: a heritable risk factor for breast cancer. , 2009, Methods in molecular biology.

[22]  C. Ruxton,et al.  The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[23]  D. Yee,et al.  Role of the IGF System in Breast Cancer Proliferation and Progression , 1999 .

[24]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[25]  M. Osborne,et al.  Omega-3 Fatty Acids: Modulation of Estrogen Metabolism and Potential for Breast Cancer Prevention , 1988 .

[26]  C Slot,et al.  Plasma creatinine determination. A new and specific Jaffe reaction method. , 1965, Scandinavian journal of clinical and laboratory investigation.